BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olefson S, Moss SF. Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer 2015;18:23-32. [PMID: 25209115 DOI: 10.1007/s10120-014-0425-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Information Committee of the Korean Gastric Cancer Association. Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2019. J Gastric Cancer 2021;21:221-35. [PMID: 34691807 DOI: 10.5230/jgc.2021.21.e27] [Reference Citation Analysis]
2 Hosoda K, Azuma M, Katada C, Ishido K, Niihara M, Ushiku H, Sakuraya M, Washio M, Wada T, Watanabe A, Harada H, Tanabe S, Koizumi W, Yamashita K, Hiki N. A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction. Int J Clin Oncol 2020;25:1090-7. [PMID: 32124094 DOI: 10.1007/s10147-020-01638-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Asadi-Lari M, Homaee-Shandiz F, Esmaeili-Hesari A. Changes in health-related quality of life in oesophagogastric cancer patients participating in palliative and curative therapies. Med J Islam Repub Iran 2018;32:31. [PMID: 30159282 DOI: 10.14196/mjiri.32.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Chen QY, Zhong Q, Wang W, Chen S, Li P, Xie JW, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Liu ZY, Zheng CH, Peng JS, Zhou ZW, Huang CM. Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional Survival. Oncologist 2019;24:e260-74. [PMID: 30470692 DOI: 10.1634/theoncologist.2018-0220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Information Committee of Korean Gastric Cancer Association. Korean Gastric Cancer Association Nationwide Survey on Gastric Cancer in 2014. J Gastric Cancer. 2016;16:131-140. [PMID: 27752390 DOI: 10.5230/jgc.2016.16.3.131] [Cited by in Crossref: 91] [Cited by in F6Publishing: 77] [Article Influence: 15.2] [Reference Citation Analysis]
6 Kim YM, Kim JH, Park JS, Baik SJ, Chun J, Youn YH, Park H. Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric Cancer 2021. [PMID: 34355281 DOI: 10.1007/s10120-021-01222-4] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xu YXZ, Mishra S. Obesity-Linked Cancers: Current Knowledge, Challenges and Limitations in Mechanistic Studies and Rodent Models. Cancers (Basel) 2018;10:E523. [PMID: 30567335 DOI: 10.3390/cancers10120523] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
8 Hirata Y, Sezaki T, Tamura-nakano M, Oyama C, Hagiwara T, Ishikawa T, Fukuda S, Yamada K, Higuchi K, Dohi T, Kawamura YI. Fatty acids in a high-fat diet potentially induce gastric parietal-cell damage and metaplasia in mice. J Gastroenterol 2017;52:889-903. [DOI: 10.1007/s00535-016-1291-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lei K, Liang X, Gao Y, Xu B, Xu Y, Li Y, Tao Y, Shi W, Liu J. Lnc-ATB contributes to gastric cancer growth through a MiR-141-3p/TGFβ2 feedback loop. Biochem Biophys Res Commun 2017;484:514-21. [PMID: 28115163 DOI: 10.1016/j.bbrc.2017.01.094] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 9.8] [Reference Citation Analysis]
10 Yang HJ, Kang D, Chang Y, Ahn J, Ryu S, Cho J, Guallar E, Sohn CI. Diabetes mellitus is associated with an increased risk of gastric cancer: a cohort study. Gastric Cancer 2020;23:382-90. [PMID: 31853749 DOI: 10.1007/s10120-019-01033-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
11 Ferreri C, Sansone A, Ferreri R, Amézaga J, Tueros I. Fatty Acids and Membrane Lipidomics in Oncology: A Cross-Road of Nutritional, Signaling and Metabolic Pathways. Metabolites 2020;10:E345. [PMID: 32854444 DOI: 10.3390/metabo10090345] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Saito T, Kurokawa Y, Takahashi T, Yamamoto K, Yamashita K, Tanaka K, Makino T, Nakajima K, Eguchi H, Doki Y. Neoadjuvant docetaxel, oxaliplatin and S‑1 (DOS) combination chemotherapy for patients with resectable adenocarcinoma of esophagogastric junction. Gastric Cancer 2022. [PMID: 35488968 DOI: 10.1007/s10120-022-01300-1] [Reference Citation Analysis]
13 Liu H, Zhou Y, Tang L. Caffeine induces sustained apoptosis of human gastric cancer cells by activating the caspase‑9/caspase‑3 signalling pathway. Mol Med Rep 2017;16:2445-54. [PMID: 28677810 DOI: 10.3892/mmr.2017.6894] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
14 Song M, Rabkin CS, Camargo MC. Gastric Cancer: an Evolving Disease. Curr Treat Options Gastroenterol. 2018;16:561-569. [PMID: 30361856 DOI: 10.1007/s11938-018-0203-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
15 Zheng J, Xie SH, Santoni G, Lagergren J. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study. Br J Cancer. 2019;121:877-882. [PMID: 31591459 DOI: 10.1038/s41416-019-0598-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
16 Jin Y, Duan LX, Xu XL, Ge WJ, Li RF, Qiu XJ, Song Y, Cao SS, Wang JG. Mechanism of apoptosis induction in human hepatocellular carcinoma cells following treatment with a gecko peptides mixture. Biomed Rep 2016;5:73-8. [PMID: 27330750 DOI: 10.3892/br.2016.664] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Ru Y, Chen XJ, Zhao ZW, Zhang PF, Feng SH, Gao Q, Gao SG, Feng XS. CyclinD1 and p57kip2 as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma. Oncotarget 2017;8:73860-70. [PMID: 29088752 DOI: 10.18632/oncotarget.18008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
18 Du X, Hidayat K, Shi BM. Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies. Biosci Rep 2017;37:BSR20160474. [PMID: 28336766 DOI: 10.1042/BSR20160474] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 6.8] [Reference Citation Analysis]
19 Sun Y, Huang XJ, Chen L. New progress in study of risk factors for gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(30): 4831-4837 [DOI: 10.11569/wcjd.v23.i30.4831] [Reference Citation Analysis]
20 Abu Freha N, Leibovici Weissman Y, Fich A, Barnes Kedar I, Halpern M, Sztarkier I, Behar DM, Arbib Sneh O, Vilkin A, Baris HN, Gingold R, Lejbkowicz F, Niv Y, Goldberg Y, Levi Z. Constitutional mismatch repair deficiency and Lynch syndrome among consecutive Arab Bedouins with colorectal cancer in Israel. Familial Cancer 2018;17:79-86. [DOI: 10.1007/s10689-017-0009-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
21 Kocoglu H, Dogan H, Oguz B, Ocak Serin S, Okuturlar Y, Gunaldi M, Erismis B, Ozdemir B, Tural D, Hursitoglu M, Harmankaya O, Kumbasar A. Comparison of Survival Rates, Tumor Stages, and Localization in between Obese and Nonobese Patients with Gastric Cancer. Gastroenterol Res Pract 2016;2016:9382750. [PMID: 27418926 DOI: 10.1155/2016/9382750] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Moss SF. The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer. Cell Mol Gastroenterol Hepatol 2017;3:183-91. [PMID: 28275685 DOI: 10.1016/j.jcmgh.2016.12.001] [Cited by in Crossref: 102] [Cited by in F6Publishing: 90] [Article Influence: 17.0] [Reference Citation Analysis]
23 Honda M, Wong SL, Healy MA, Nakajima T, Watanabe M, Fukuma S, Fukuhara S, Ayanian JZ. Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States. J Cancer 2017;8:1935-42. [PMID: 28819392 DOI: 10.7150/jca.19174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
24 Sogabe M, Okahisa T, Kimura T, Okamoto K, Miyamoto H, Muguruma N, Takayama T. Influence of metabolic syndrome on upper gastrointestinal disease. Clin J Gastroenterol 2016;9:191-202. [DOI: 10.1007/s12328-016-0668-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
25 Güzel K, Ocak ÖK, Ergenc H, Ergenc Z, Gökosmanoğlu F. Cancers Detected During the Evaluation Before Bariatric Surgery in Obese Patients: a High-Risk Population for Cancers and Their Prevalence. Obes Surg 2021;31:5391-5. [PMID: 34674140 DOI: 10.1007/s11695-021-05747-6] [Reference Citation Analysis]
26 Zhang Y, Zhang P, Rong Z, Huang C. One stomach, two subtypes of carcinoma—the differences between distal and proximal gastric cancer. Gastroenterology Report 2021;9:489-504. [DOI: 10.1093/gastro/goab050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Shao D, Vogtmann E, Liu A, Qin J, Chen W, Abnet CC, Wei W. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer 2019;125:3993-4002. [PMID: 31355925 DOI: 10.1002/cncr.32403] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
28 Kim JJ. Epidemiology of Gastroesophageal Junction Adenocarcinoma in Korea. J Gastric Cancer 2018;18:328-38. [PMID: 30607296 DOI: 10.5230/jgc.2018.18.e38] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Steffen A, Huerta JM, Weiderpass E, Bueno-de-Mesquita HB, May AM, Siersema PD, Kaaks R, Neamat-Allah J, Pala V, Panico S, Saieva C, Tumino R, Naccarati A, Dorronsoro M, Sánchez-Cantalejo E, Ardanaz E, Quirós JR, Ohlsson B, Johansson M, Wallner B, Overvad K, Halkjaer J, Tjønneland A, Fagherazzi G, Racine A, Clavel-Chapelon F, Key TJ, Khaw KT, Wareham N, Lagiou P, Bamia C, Trichopoulou A, Ferrari P, Freisling H, Lu Y, Riboli E, Cross AJ, Gonzalez CA, Boeing H. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2015;137:646-57. [PMID: 25598323 DOI: 10.1002/ijc.29432] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]